SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Research and development for neglected diseases: more is still needed, and faster
6 references·0 citing·26 second hop
Research and development for neglected diseases: more is still needed, and faster (2013)Research and development for neglected di…The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment (2013)The drug and vaccine landscap…Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012)Global and regional mortality…Public-private partnership: from there to here (2005)Public-private partnership: f…A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need (2005)A Breakthrough in R&D for Neg…Virtual drug discovery and development for neglected diseases through public–private partnerships (2003)Virtual drug discovery and de…Drug development for neglected diseases: a deficient market and a public-health policy failure (2002)Drug development for neglecte…Access to Essential Drugs in Poor Countries (1999)The price of innovation: new estimates of drug development costs (2003)Towards an Understanding of the Right to Enjoy the Benefits of Scientific Progress and Its Applications (2009)In the shadow: illegal markets and economic sociology (2012)Why miltefosine—a life-saving drug for leishmaniasis—is unavailable to people who need it the most (2018)Can the pharmaceutical industry reduce attrition rates? (2004)Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory? (2013)Making technological innovation work for sustainable development (2016)Toward a New Common Sense (2021)The world health report 2001 - Mental health: new understanding, new hope (2001)Armed Conflict 1946-2001: A New Dataset (2002)Counting the dead and what they died from: an assessment of the global status of cause of death data. (2005)Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 (2013)Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014)Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016)Human Development Report 2001: Making new technologies work for human development (2001)Intellectual property rights, the WTO and developing countries: the TRIPS agreement and policy options (2001)25 years of the WHO essential medicines lists: progress and challenges (2003)HUMAN RIGHTS AND GLOBAL HEALTH: A RESEARCH PROGRAM (2005)Cost of innovation in the pharmaceutical industry (1991)Priority medicines for Europe and the world (2004)Advancing Drug Innovation for Neglected Diseases—Criteria for Lead Progression (2009)Exploring different approaches to improve the success of drug discovery and development projects: a review (2020)Docking for Neglected Diseases as Community Efforts (2008)The role of Product Development Partnerships in research and development for neglected diseases (2010)Integrating Infrastructure and Clinical Management in PPPs for Health Care (2013)
this work references cited by second hop

References

  • 2012Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 201014,083 cited
  • 2002Drug development for neglected diseases: a deficient market and a public-health policy failure895 cited
  • 2013The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment352 cited
  • 2003Virtual drug discovery and development for neglected diseases through public–private partnerships259 cited
  • 2005A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need197 cited
  • 2005Public-private partnership: from there to here90 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work